Walleye Capital LLC Vbi Vaccines Inc Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.27 - $2.47 $34,303 - $66,717	-27,011 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$2.21 - $3.22 $19,410 - $28,281	8,783 Added 48.18%	27,011 $63,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $51,038 - $67,808	18,228 New	18,228 $57,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $34,400 - $56,000	-16,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $44,320 - $98,720	16,000 New	16,000 $46,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.